MentionFox
Home › funding signals › Auron Therapeutics, Inc.
Company · SEC filings

Auron Therapeutics, Inc. funding history

Auron Therapeutics, Inc. has 4 Form D filings on record, from 2023-10-20 to 2026-08-13. Together its new offerings report $7.12M sold.

Funding historyFounders and team

What do you want to do with Auron Therapeutics, Inc.?

Based
Wellesley, MASSACHUSETTS
Industry group
Biotechnology
Filings
4
Raised (new offerings)
$7.12M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-08-13New offering
first sale 2026-08-10
$7.12M$12MSEC filing
2025-12-23Amendment
first sale 2024-12-18
$27.29M$42.29MSEC filing
2024-12-31Filing——SEC filing
2023-10-20Amendment——SEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Auron Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/auron-therapeutics-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Auron Therapeutics, Inc. funding history: 4 SEC filings, $7.12M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/auron-therapeutics-inc